Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

3.62
Delayed Data
As of 12:44pm ET
 +0.04 / +1.12%
Today’s Change
2.01
Today|||52-Week Range
5.74
+12.77%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close3.58
Today’s open3.61
Day’s range3.51 - 3.74
Volume53,075
Average volume (3 months)130,628
Market cap$92.3M
Data as of 12:44pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+6.94%
Earnings growth (this year)-15.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.53%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CYTRCytRx Corp-0.02-0.84%
PFNXPfenex Inc-0.05-1.50%
SRRASierra Oncology Inc+0.07+2.37%
CFRXContraFect Corp+0.03+2.66%
Data as of 1:22pm ET, 01/18/2018

Financials

Next reporting dateMarch 30, 2018
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$10.7M
Annual profit (last year)-$19.5M
Net profit margin-183.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial &
Principal Accounting Officer, VP
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts